High-throughput approaches for precision medicine in high-grade serous ovarian cancer
出版年份 2020 全文链接
标题
High-throughput approaches for precision medicine in high-grade serous ovarian cancer
作者
关键词
-
出版物
Journal of Hematology & Oncology
Volume 13, Issue 1, Pages -
出版商
Springer Science and Business Media LLC
发表日期
2020-10-09
DOI
10.1186/s13045-020-00971-6
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- SurfaceGenie: a web-based application for prioritizing cell-type specific marker candidates
- (2020) Matthew Waas et al. BIOINFORMATICS
- Genetic heterogeneity and evolutionary history of high-grade ovarian carcinoma and matched distant metastases
- (2020) Tariq Masoodi et al. BRITISH JOURNAL OF CANCER
- Cancer statistics, 2020
- (2020) Rebecca L. Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- The Repertoire of Serous Ovarian Cancer Non-genetic Heterogeneity Revealed by Single-Cell Sequencing of Normal Fallopian Tube Epithelial Cells
- (2020) Zhiyuan Hu et al. CANCER CELL
- Functional proteomics interrogation of the kinome identifies MRCKA as a therapeutic target in high-grade serous ovarian carcinoma
- (2020) Alison M. Kurimchak et al. Science Signaling
- Distinct fibroblast functional states drive clinical outcomes in ovarian cancer and are regulated by TCF21
- (2020) Ali Hussain et al. JOURNAL OF EXPERIMENTAL MEDICINE
- TP53 Mutations in Serum Circulating Cell-Free Tumor DNA As Longitudinal Biomarker for High-Grade Serous Ovarian Cancer
- (2020) Silvia R. Vitale et al. Biomolecules
- A single-cell landscape of high-grade serous ovarian cancer
- (2020) Benjamin Izar et al. NATURE MEDICINE
- Evaluation of Dunphy et al.: Suggestions to Solidify, Clarify, and Focus without Substantial New Work
- (2019) Michael Springer Cell Systems
- Genetic Screens Reveal FEN1 and APEX2 as BRCA2 Synthetic Lethal Targets
- (2019) Kristen E. Mengwasser et al. MOLECULAR CELL
- Epithelial ovarian cancer
- (2019) Stephanie Lheureux et al. LANCET
- Role of human epididymis protein 4 (HE4) in detecting recurrence in CA125 negative ovarian cancer patients
- (2019) Francesco Plotti et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
- Proteomics reveals NNMT as a master metabolic regulator of cancer-associated fibroblasts
- (2019) Mark A. Eckert et al. NATURE
- Prioritization of cancer therapeutic targets using CRISPR–Cas9 screens
- (2019) Fiona M. Behan et al. NATURE
- An organoid platform for ovarian cancer captures intra- and interpatient heterogeneity
- (2019) Oded Kopper et al. NATURE MEDICINE
- The proteomic comparison of peripheral circulation-derived exosomes from the epithelial ovarian carcinoma (EOC) patients and non-EOC subjects
- (2019) Peng Peng et al. Translational Cancer Research
- Ovarian Cancer Immunotherapy: Turning up the Heat
- (2019) Eleonora Ghisoni et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Final Overall Survival of a Randomized Trial of Bevacizumab for Primary Treatment of Ovarian Cancer
- (2019) Krishnansu S. Tewari et al. JOURNAL OF CLINICAL ONCOLOGY
- Final results from GCIG/ENGOT/AGO‐OVAR 12, a randomised placebo‐controlled phase III trial of nintedanib combined with chemotherapy for newly diagnosed advanced ovarian cancer
- (2019) Isabelle Ray‐Coquard et al. INTERNATIONAL JOURNAL OF CANCER
- Quantitative high-throughput screening using an organotypic model identifies compounds that inhibit ovarian cancer metastasis.
- (2019) Hilary A Kenny et al. MOLECULAR CANCER THERAPEUTICS
- Niraparib in Patients with Newly Diagnosed Advanced Ovarian Cancer
- (2019) Antonio González-Martín et al. NEW ENGLAND JOURNAL OF MEDICINE
- Mass Spectrometry-Based Plasma Proteomics: Considerations from Sample Collection to Achieving Translational Data
- (2019) Vera Ignjatovic et al. JOURNAL OF PROTEOME RESEARCH
- Mesothelial Cell HIF1α Expression Is Metabolically Downregulated by Metformin to Prevent Oncogenic Tumor-Stromal Crosstalk
- (2019) Peter C. Hart et al. Cell Reports
- Ovarian cancer statistics, 2018
- (2018) Lindsey A. Torre et al. CA-A CANCER JOURNAL FOR CLINICIANS
- FORWARD I: a Phase III study of mirvetuximab soravtansine versus chemotherapy in platinum-resistant ovarian cancer
- (2018) Kathleen N Moore et al. Future Oncology
- Combining serum microRNA and CA-125 as prognostic indicators of preoperative surgical outcome in women with high-grade serous ovarian cancer
- (2018) Jaynish S. Shah et al. GYNECOLOGIC ONCOLOGY
- Ovarian Cancer Prevention and Screening
- (2018) Usha Menon et al. OBSTETRICS AND GYNECOLOGY
- Detection and localization of surgically resectable cancers with a multi-analyte blood test
- (2018) Joshua D. Cohen et al. SCIENCE
- Targeting RAS-driven human cancer cells with antibodies to upregulated and essential cell-surface proteins
- (2018) Alexander J Martinko et al. eLife
- Profiling circulating tumour cells and other biomarkers of invasive cancers
- (2018) Mahla Poudineh et al. Nature Biomedical Engineering
- Multi-level Proteomics Identifies CT45 as a Chemosensitivity Mediator and Immunotherapy Target in Ovarian Cancer
- (2018) Fabian Coscia et al. CELL
- Analysis of Circulating Tumor Cells in Ovarian Cancer and Their Clinical Value as a Biomarker
- (2018) Xuehui Zhang et al. CELLULAR PHYSIOLOGY AND BIOCHEMISTRY
- Copy number signatures and mutational processes in ovarian carcinoma
- (2018) Geoff Macintyre et al. NATURE GENETICS
- Exosomal miR-1290 is a potential biomarker of high-grade serous ovarian carcinoma and can discriminate patients from those with malignancies of other histological types
- (2018) Masaki Kobayashi et al. Journal of Ovarian Research
- Extracellular vesicle-associated miRNAs in ovarian cancer – design of an integrated NGS-based workflow for the identification of blood-based biomarkers for platinum-resistance
- (2018) Jan Dominik Kuhlmann et al. CLINICAL CHEMISTRY AND LABORATORY MEDICINE
- Sensitive tumour detection and classification using plasma cell-free DNA methylomes
- (2018) Shu Yi Shen et al. NATURE
- Maintenance Olaparib in Patients with Newly Diagnosed Advanced Ovarian Cancer
- (2018) Kathleen Moore et al. NEW ENGLAND JOURNAL OF MEDICINE
- Double-slit photoelectron interference in strong-field ionization of the neon dimer
- (2018) Maksim Kunitski et al. Nature Communications
- Targeting MYC dependency in ovarian cancer through inhibition of CDK7 and CDK12/13
- (2018) Mei Zeng et al. eLife
- Predictive value of circulating tumor cells (CTCs) captured by microfluidic device in patients with epithelial ovarian cancer
- (2017) Maria Lee et al. GYNECOLOGIC ONCOLOGY
- Antitumor activity and safety of the PARP inhibitor rucaparib in patients with high-grade ovarian carcinoma and a germline or somatic BRCA1 or BRCA2 mutation: Integrated analysis of data from Study 10 and ARIEL2
- (2017) Amit M. Oza et al. GYNECOLOGIC ONCOLOGY
- Risks of Breast, Ovarian, and Contralateral Breast Cancer for BRCA1 and BRCA2 Mutation Carriers
- (2017) Karoline B. Kuchenbaecker et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Reversion of BRCA1/2 Germline Mutations Detected in Circulating Tumor DNA From Patients With High-Grade Serous Ovarian Cancer
- (2017) Elizabeth L. Christie et al. JOURNAL OF CLINICAL ONCOLOGY
- High-grade serous carcinomas arise in the mouse oviduct via defects linked to the human disease
- (2017) Yali Zhai et al. JOURNAL OF PATHOLOGY
- Rucaparib maintenance treatment for recurrent ovarian carcinoma after response to platinum therapy (ARIEL3): a randomised, double-blind, placebo-controlled, phase 3 trial
- (2017) Robert L Coleman et al. LANCET
- Olaparib tablets as maintenance therapy in patients with platinum-sensitive, relapsed ovarian cancer and a BRCA1/2 mutation (SOLO2/ENGOT-Ov21): a double-blind, randomised, placebo-controlled, phase 3 trial
- (2017) Eric Pujade-Lauraine et al. LANCET ONCOLOGY
- High grade serous ovarian carcinomas originate in the fallopian tube
- (2017) S. Intidhar Labidi-Galy et al. Nature Communications
- Interrogation of Functional Cell-Surface Markers Identifies CD151 Dependency in High-Grade Serous Ovarian Cancer
- (2017) Mauricio Medrano et al. Cell Reports
- Erratum to: Mutational landscape of mucinous ovarian carcinoma and its neoplastic precursors
- (2017) Georgina L. Ryland et al. Genome Medicine
- The Dualistic Model of Ovarian Carcinogenesis
- (2016) Robert J. Kurman et al. AMERICAN JOURNAL OF PATHOLOGY
- Olaparib monotherapy in patients with advanced relapsed ovarian cancer and a germlineBRCA1/2mutation: a multistudy analysis of response rates and safety
- (2016) U. A. Matulonis et al. ANNALS OF ONCOLOGY
- Antibody-drug conjugates—an emerging class of cancer treatment
- (2016) Nikolaos Diamantis et al. BRITISH JOURNAL OF CANCER
- Integrated Proteogenomic Characterization of Human High-Grade Serous Ovarian Cancer
- (2016) Hui Zhang et al. CELL
- Biological roles of glycans
- (2016) Ajit Varki GLYCOBIOLOGY
- Is the Risk of Ovarian Malignancy Algorithm Better Than Other Tests for Predicting Ovarian Malignancy in Women with Pelvic Masses?
- (2016) Marut Yanaranop et al. GYNECOLOGIC AND OBSTETRIC INVESTIGATION
- Extended mortality results for ovarian cancer screening in the PLCO trial with median 15 years follow-up
- (2016) Paul F. Pinsky et al. GYNECOLOGIC ONCOLOGY
- Identification of novel candidate plasma metabolite biomarkers for distinguishing serous ovarian carcinoma and benign serous ovarian tumors
- (2016) Matthew F. Buas et al. GYNECOLOGIC ONCOLOGY
- Molecular Alterations of TP53 are a Defining Feature of Ovarian High-Grade Serous Carcinoma
- (2016) Russell Vang et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY
- Neoadjuvant Chemotherapy for Newly Diagnosed, Advanced Ovarian Cancer: Society of Gynecologic Oncology and American Society of Clinical Oncology Clinical Practice Guideline
- (2016) Alexi A. Wright et al. JOURNAL OF CLINICAL ONCOLOGY
- Ovarian cancer screening and mortality in the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS): a randomised controlled trial
- (2016) Ian J Jacobs et al. LANCET
- Divergent modes of clonal spread and intraperitoneal mixing in high-grade serous ovarian cancer
- (2016) Andrew McPherson et al. NATURE GENETICS
- Niraparib Maintenance Therapy in Platinum-Sensitive, Recurrent Ovarian Cancer
- (2016) Mansoor R. Mirza et al. NEW ENGLAND JOURNAL OF MEDICINE
- Profile of farletuzumab and its potential in the treatment of solid tumors
- (2016) Seiya Sato et al. OncoTargets and Therapy
- Integrative proteomic profiling of ovarian cancer cell lines reveals precursor cell associated proteins and functional status
- (2016) F. Coscia et al. Nature Communications
- Exploratory Analysis of TP53 Mutations in Circulating Tumour DNA as Biomarkers of Treatment Response for Patients with Relapsed High-Grade Serous Ovarian Carcinoma: A Retrospective Study
- (2016) Christine A. Parkinson et al. PLOS MEDICINE
- Ultrastructural Characterization of the Lower Motor System in a Mouse Model of Krabbe Disease
- (2016) Valentina Cappello et al. Scientific Reports
- Antibody-drug conjugates as novel anti-cancer chemotherapeutics
- (2015) C. Peters et al. BIOSCIENCE REPORTS
- Final overall survival and safety analysis of OCEANS, a phase 3 trial of chemotherapy with or without bevacizumab in patients with platinum-sensitive recurrent ovarian cancer
- (2015) Carol Aghajanian et al. GYNECOLOGIC ONCOLOGY
- Society of Gynecologic Oncology statement on risk assessment for inherited gynecologic cancer predispositions
- (2015) Johnathan M. Lancaster et al. GYNECOLOGIC ONCOLOGY
- Beyond genomics: Critical evaluation of cell line utility for ovarian cancer research
- (2015) Kevin M. Elias et al. GYNECOLOGIC ONCOLOGY
- In vivo tumor growth of high-grade serous ovarian cancer cell lines
- (2015) Anirban K. Mitra et al. GYNECOLOGIC ONCOLOGY
- Effectiveness of the Risk of Malignancy Index and the Risk of Ovarian Malignancy Algorithm in a Cohort of Women With Ovarian Cancer
- (2015) Genevieve K. Lennox et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
- Efficient molecular subtype classification of high-grade serous ovarian cancer
- (2015) Huei San Leong et al. JOURNAL OF PATHOLOGY
- Primary chemotherapy versus primary surgery for newly diagnosed advanced ovarian cancer (CHORUS): an open-label, randomised, controlled, non-inferiority trial
- (2015) Sean Kehoe et al. LANCET
- Standard chemotherapy with or without bevacizumab for women with newly diagnosed ovarian cancer (ICON7): overall survival results of a phase 3 randomised trial
- (2015) Amit M Oza et al. LANCET ONCOLOGY
- An Integrated Platform for Isolation, Processing, and Mass Spectrometry-based Proteomic Profiling of Rare Cells in Whole Blood
- (2015) Siyang Li et al. MOLECULAR & CELLULAR PROTEOMICS
- PARPs and ADP-Ribosylation: 50 Years … and Counting
- (2015) W. Lee Kraus MOLECULAR CELL
- RNA-Seq of single prostate CTCs implicates noncanonical Wnt signaling in antiandrogen resistance
- (2015) D. T. Miyamoto et al. SCIENCE
- The role of HE4 for prediction of recurrence in epithelial ovarian cancer patients—results from the OVCAD study
- (2015) Mani Nassir et al. TUMOR BIOLOGY
- Quantitative analysis of cell-free DNA in ovarian cancer
- (2015) XUEFENG SHAO et al. Oncology Letters
- Homologous Recombination Deficiency: Exploiting the Fundamental Vulnerability of Ovarian Cancer
- (2015) P. A. Konstantinopoulos et al. Cancer Discovery
- Spatial and Temporal Heterogeneity in High-Grade Serous Ovarian Cancer: A Phylogenetic Analysis
- (2015) Roland F. Schwarz et al. PLOS MEDICINE
- Patient-Derived Ovarian Tumor Xenografts Recapitulate Human Clinicopathology and Genetic Alterations
- (2014) F. Ricci et al. CANCER RESEARCH
- Tumorgrafts asIn VivoSurrogates for Women with Ovarian Cancer
- (2014) S. John Weroha et al. CLINICAL CANCER RESEARCH
- Prognostic analysis of invasive circulating tumor cells (iCTCs) in epithelial ovarian cancer
- (2014) Michael L. Pearl et al. GYNECOLOGIC ONCOLOGY
- Methodological challenges in utilizing miRNAs as circulating biomarkers
- (2014) Leni Moldovan et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Bevacizumab Combined With Chemotherapy for Platinum-Resistant Recurrent Ovarian Cancer: The AURELIA Open-Label Randomized Phase III Trial
- (2014) Eric Pujade-Lauraine et al. JOURNAL OF CLINICAL ONCOLOGY
- Incorporation of Pazopanib in Maintenance Therapy of Ovarian Cancer
- (2014) Andreas du Bois et al. JOURNAL OF CLINICAL ONCOLOGY
- A genetically engineered ovarian cancer mouse model based on fallopian tube transformation mimics human high-grade serous carcinoma development
- (2014) Cheryl A Sherman-Baust et al. JOURNAL OF PATHOLOGY
- Molecular correlates of platinum response in human high-grade serous ovarian cancer patient-derived xenografts
- (2014) Monique D. Topp et al. Molecular Oncology
- Ovarian Cancer Spheroid Cells with Stem Cell-Like Properties Contribute to Tumor Generation, Metastasis and Chemotherapy Resistance through Hypoxia-Resistant Metabolism
- (2014) Jianqun Liao et al. PLoS One
- An in-tumor genetic screen reveals that the BET bromodomain protein, BRD4, is a potential therapeutic target in ovarian carcinoma
- (2014) Maria Giuseppina Baratta et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Detection of Circulating Tumor DNA in Early- and Late-Stage Human Malignancies
- (2014) C. Bettegowda et al. Science Translational Medicine
- Evaluating the risk of ovarian cancer before surgery using the ADNEX model to differentiate between benign, borderline, early and advanced stage invasive, and secondary metastatic tumours: prospective multicentre diagnostic study
- (2014) B. Van Calster et al. BMJ-British Medical Journal
- Origin and molecular pathogenesis of ovarian high-grade serous carcinoma
- (2013) R. J. Kurman ANNALS OF ONCOLOGY
- BRCA1 expression and improved survival in ovarian cancer patients treated with intraperitoneal cisplatin and paclitaxel: a Gynecologic Oncology Group Study
- (2013) J L Lesnock et al. BRITISH JOURNAL OF CANCER
- Transformation of the Fallopian Tube Secretory Epithelium Leads to High-Grade Serous Ovarian Cancer in Brca;Tp53;Pten Models
- (2013) Ruth Perets et al. CANCER CELL
- Genomic and transcriptomic plasticity in treatment-naive ovarian cancer
- (2013) M. Hoogstraat et al. GENOME RESEARCH
- Predictive value of circulating tumor cells (CTCs) in newly-diagnosed and recurrent ovarian cancer patients
- (2013) Joyce F. Liu et al. GYNECOLOGIC ONCOLOGY
- Distinct evolutionary trajectories of primary high-grade serous ovarian cancers revealed through spatial mutational profiling
- (2013) Ali Bashashati et al. JOURNAL OF PATHOLOGY
- Serum Glycome Profiling: A Biomarker for Diagnosis of Ovarian Cancer
- (2013) Karina Biskup et al. JOURNAL OF PROTEOME RESEARCH
- Cancer Risks for BRCA1 and BRCA2 Mutation Carriers: Results From Prospective Analysis of EMBRACE
- (2013) Nasim Mavaddat et al. JNCI-Journal of the National Cancer Institute
- Epithelial ovarian cancer experimental models
- (2013) E Lengyel et al. ONCOGENE
- Evaluating cell lines as tumour models by comparison of genomic profiles
- (2013) Silvia Domcke et al. Nature Communications
- Modeling High-Grade Serous Carcinoma: How Converging Insights into Pathogenesis and Genetics are Driving Better Experimental Platforms
- (2013) Paul Michael Jones et al. Frontiers in Oncology
- A randomised controlled trial of a theory-based intervention to improve sun protective behaviour in adolescents ('you can still be HOT in the shade'): study protocol
- (2012) Anna L Hawkes et al. BMC CANCER
- Cancer statistics, 2012
- (2012) Rebecca Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- The Promise of Patient-Derived Xenografts: The Best Laid Plans of Mice and Men
- (2012) S. Kopetz et al. CLINICAL CANCER RESEARCH
- Ovarian malignancy risk stratification of the adnexal mass using a multivariate index assay
- (2012) Robert E. Bristow et al. GYNECOLOGIC ONCOLOGY
- Differential Diagnosis of a Pelvic Mass
- (2012) Robert C. Bast et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
- BRCA Mutation Frequency and Patterns of Treatment Response in BRCA Mutation–Positive Women With Ovarian Cancer: A Report From the Australian Ovarian Cancer Study Group
- (2012) Kathryn Alsop et al. JOURNAL OF CLINICAL ONCOLOGY
- OCEANS: A Randomized, Double-Blind, Placebo-Controlled Phase III Trial of Chemotherapy With or Without Bevacizumab in Patients With Platinum-Sensitive Recurrent Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancer
- (2012) Carol Aghajanian et al. JOURNAL OF CLINICAL ONCOLOGY
- Association between endometriosis and risk of histological subtypes of ovarian cancer: a pooled analysis of case–control studies
- (2012) Celeste Leigh Pearce et al. LANCET ONCOLOGY
- Diagnosing the decline in pharmaceutical R&D efficiency
- (2012) Jack W. Scannell et al. NATURE REVIEWS DRUG DISCOVERY
- Olaparib Maintenance Therapy in Platinum-Sensitive Relapsed Ovarian Cancer
- (2012) Jonathan Ledermann et al. NEW ENGLAND JOURNAL OF MEDICINE
- Argonaute 2 Complexes Selectively Protect the Circulating MicroRNAs in Cell-Secreted Microvesicles
- (2012) Limin Li et al. PLoS One
- High-grade serous ovarian cancer arises from fallopian tube in a mouse model
- (2012) J. Kim et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Does HE4 have a role as biomarker in the recurrence of ovarian cancer?
- (2012) Francesco Plotti et al. TUMOR BIOLOGY
- CA125 surveillance increases optimal resectability at secondary cytoreductive surgery for recurrent epithelial ovarian cancer
- (2011) Nicole D. Fleming et al. GYNECOLOGIC ONCOLOGY
- Evaluation of ovarian cancer remission markers HE4, MMP7 and Mesothelin by comparison to the established marker CA125
- (2011) Michèl Schummer et al. GYNECOLOGIC ONCOLOGY
- Integrated genomic analyses of ovarian carcinoma
- (2011) D. Bell et al. NATURE
- Incorporation of Bevacizumab in the Primary Treatment of Ovarian Cancer
- (2011) Robert A. Burger et al. NEW ENGLAND JOURNAL OF MEDICINE
- A Phase 3 Trial of Bevacizumab in Ovarian Cancer
- (2011) Timothy J. Perren et al. NEW ENGLAND JOURNAL OF MEDICINE
- Performance of the American College of Obstetricians and Gynecologistsʼ Ovarian Tumor Referral Guidelines With a Multivariate Index Assay
- (2011) Rachel Ware Miller et al. OBSTETRICS AND GYNECOLOGY
- Evaluation of the Diagnostic Accuracy of the Risk of Ovarian Malignancy Algorithm in Women With a Pelvic Mass
- (2011) Richard G. Moore et al. OBSTETRICS AND GYNECOLOGY
- Effectiveness of a Multivariate Index Assay in the Preoperative Assessment of Ovarian Tumors
- (2011) Frederick R. Ueland et al. OBSTETRICS AND GYNECOLOGY
- Mutations in 12 genes for inherited ovarian, fallopian tube, and peritoneal carcinoma identified by massively parallel sequencing
- (2011) T. Walsh et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Systematic investigation of genetic vulnerabilities across cancer cell lines reveals lineage-specific dependencies in ovarian cancer
- (2011) H. W. Cheung et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Essential Gene Profiles in Breast, Pancreatic, and Ovarian Cancer Cells
- (2011) Richard Marcotte et al. Cancer Discovery
- Comparison of a novel multiple marker assay vs the Risk of Malignancy Index for the prediction of epithelial ovarian cancer in patients with a pelvic mass
- (2010) Richard G. Moore et al. AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY
- The Road from Discovery to Clinical Diagnostics: Lessons Learned from the First FDA-Cleared In Vitro Diagnostic Multivariate Index Assay of Proteomic Biomarkers
- (2010) Z. Zhang et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- Rapid Mass Spectrometric Metabolic Profiling of Blood Sera Detects Ovarian Cancer with High Accuracy
- (2010) M. Zhou et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- Driver mutations in TP53 are ubiquitous in high grade serous carcinoma of the ovary
- (2010) Ahmed Ashour Ahmed et al. JOURNAL OF PATHOLOGY
- Early versus delayed treatment of relapsed ovarian cancer (MRC OV05/EORTC 55955): a randomised trial
- (2010) Gordon JS Rustin et al. LANCET
- Neoadjuvant Chemotherapy or Primary Surgery in Stage IIIC or IV Ovarian Cancer
- (2010) Ignace Vergote et al. NEW ENGLAND JOURNAL OF MEDICINE
- Levels of Circulating Cell-Free Nuclear and Mitochondrial DNA in Benign and Malignant Ovarian Tumors
- (2010) Rebecca R. Zachariah et al. OBSTETRICS AND GYNECOLOGY
- HE4: a new potential early biomarker for the recurrence of ovarian cancer
- (2010) Emanuela Anastasi et al. TUMOR BIOLOGY
- Serum HE4 concentration differentiates malignant ovarian tumours from ovarian endometriotic cysts
- (2009) K Huhtinen et al. BRITISH JOURNAL OF CANCER
- The early detection of ovarian cancer: from traditional methods to proteomics. Can we really do better than serum CA-125?
- (2008) Vladimir Nossov et al. AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY
- Novel Molecular Subtypes of Serous and Endometrioid Ovarian Cancer Linked to Clinical Outcome
- (2008) R. W. Tothill et al. CLINICAL CANCER RESEARCH
- MicroRNA signatures of tumor-derived exosomes as diagnostic biomarkers of ovarian cancer
- (2008) Douglas D. Taylor et al. GYNECOLOGIC ONCOLOGY
- A novel multiple marker bioassay utilizing HE4 and CA125 for the prediction of ovarian cancer in patients with a pelvic mass
- (2008) Richard G. Moore et al. GYNECOLOGIC ONCOLOGY
- Circulating microRNAs as stable blood-based markers for cancer detection
- (2008) P. S. Mitchell et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The use of multiple novel tumor biomarkers for the detection of ovarian carcinoma in patients with a pelvic mass
- (2007) Richard G. Moore et al. GYNECOLOGIC ONCOLOGY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started